Enjoy complimentary customisation on priority with our Enterprise License!
The global biosurgery market size has the potential to grow by USD 4.81 billion during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period.
This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and product (soft-tissue attachments, hemostatic agents, bone graft substitutes, surgical sealants, and adhesives, and adhesion barriers). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CSL Ltd., Getinge AB, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc., and Stryker Corp.
The biosurgery market is currently fragmented. However, the degree of fragmentation will decrease over the forecast period. Vendors are opting for various growth strategies such as new product launches to sustain in a competitive market. Johnson & Johnson, Medtronic Plc, Pfizer Inc., and Stryker Corp. are a few of the significant market participants.
Although the accelerating market growth momentum will offer immense business opportunities to vendors, the availability of substitutes will challenge the growth of many. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market positions, this biosurgery market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of the companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. This biosurgery market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading biosurgery companies, including:
North America accounted for the largest market share in 2019. The increasing number of surgical procedures, growing adoption of advanced technologies, rising healthcare expenditure, and new product launches are contributing to the biosurgery market growth in North America.
Over 40% of the overall market’s growth will originate from North America during the forecast period. The US is the critical market for biosurgery in the region. The market growth rate in this region will be slower than that of Asia and Europe over the forecast period.
Soft-tissue attachments are majorly used to replace damaged joint surfaces in orthopedic endoprostheses. Synthetic and biological meshes are used as soft-tissue attachments. The increased biocompatibility, reduced chances of infections, and the biodegradable nature of biological meshes is driving their demand in the global biosurgery market. As a result, the biosurgery market growth by the soft-tissue attachments segment will be significant over the forecast period.
The growth rate of the soft-tissue attachments segment is expected to be slower compared with the hemostatic agents segment over the forecast period. This report provides an accurate prediction of the contribution of all the segments to the growth of the biosurgery market size.
The rising prevalence of various chronic and lifestyle conditions such as cancer, cardiovascular diseases, bone conditions, and others has increased the number of surgical procedures, which have augmented the use of biosurgery products. Procedures such as coronary angioplasty or stent replacement, coronary artery bypass graft (CABG), repair or replacement of heart valves, joint replacement, and orthopedic surgeries, which involve blood loss and tissue damage, require biosurgery products. The procedures mentioned include the use of hemostatic agents, surgical sealants, adhesion barriers, and bone graft substitutes to prevent blood loss and repair damaged tissues or bones. Therefore, the growing number of orthopedic and cardiovascular surgeries will primarily contribute to the biosurgery market growth over the forecast period.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.